Unibest

Pharmaceutical intermediates

Orforglipron Intermediates

24 pharmaceutical intermediates for Orforglipron.

About Orforglipron

Originator
CHUGAI PHARMACEUTICAL CO., LTD.

Available intermediates

24 intermediates currently listed for Orforglipron. Request specifications, documentation or a quotation for any item below.

Orforglipron intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
N-Boc-L-Alaninol79069-13-9//
(4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride2212021-40-2//
tert-buty1 (S)-3-amino-2-(4- fluoro-3,5- dimethylpheny1)-4- methyl-2,4,6,7-tetrahydro-5H-pyrazoloB ,3-c ]pyridine-5-carboxylate2212021-59-3//
(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate2212021-56-0//
2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5- dimethylpheny1)-4,5,6,7-2H-Imidazol-2-one, 1-[(4S)-2- (4-fluoro-3,5-dimethylpheny1)-4,5,6,7-1H- indazol-5- yl)- 1,3-dihydro-2212022-56-3//
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-2212021-61-7//
H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-2212021-81-1//
5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid2212021-83-3//
(R)-4-Benzyl-2-oxazolidinone102029-44-7//
5-Bromo-4-fluoro-1-methyl-1H-indazole1784678-61-0//
5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid2212021-83-3//
1-(4-fluoro-1-methyl-1H-indazole-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-3-yl)-1,3-dihydro-2H-imidazole-2-one hydrochloride3036782-75-6//
3-(3-(4-fluoro-1-methyl-1H-indazole-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester3036782-74-5//
tert-butyl 2-(4-fluoro-3,5-dimethylphenyl)-3-(2-oxo-1H-imidazol-3-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate2212022-03-0//
tert-butyl 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate2212021-41-3//
5-Bromoindole-2-carboxylic acid7254-19-5//
5-bromo-N-methyl-N-phenyl-1H-indole-2-carboxamide2860499-50-7//
(S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide2212021-79-7//
1-(cyanomethyl)-5-[(4S)-2,2-dimethyloxan-4-yl]-N-methyl-N-phenylindole-2-carboxamide2212021-80-0//
(E)-3-(2-(methyl(phenyl)carbamoyl)-1H-indol-5-yl)acrylic acid3047292-97-4//
(R,E)-N-methyl-5-(3-oxo-3-(2-oxo-4-phenyloxazolidin-3-yl)prop-1-en-1-yl)-N-phenyl-1H-indole-2-carboxamide3047293-00-2//
(S)-3-Aminobutanenitrile Hydrochloride1073666-54-2//
5-Bromo-2-fluoro-m-xylene99725-44-7//
1,3,2-Dioxathiolane, 4-Methyl-, 2,2-dioxide, (4R)-1006381-03-8//

Building toward Orforglipron?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

我们能如何帮助您?

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →